We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+32.2%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$2.52B
AUM Growth
+$1.12B
(+80%)
Cap. Flow
+$772M
Cap. Flow
% of AUM
30.59%
Top 10 Holdings %
Top 10 Hldgs %
26.22%
Holding
205
New
69
Increased
52
Reduced
26
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$62.5M |
| 2 |
Johnson & Johnson
JNJ
|
+$61M |
| 3 |
Fidelity National Information Services
FIS
|
+$54.2M |
| 4 |
KLA
KLAC
|
+$44.1M |
| 5 |
PayPal
PYPL
|
+$41.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$65.7M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$46.8M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$46.5M |
| 4 |
IMMU
Immunomedics Inc
IMMU
|
+$41.2M |
| 5 |
Analog Devices
ADI
|
+$23.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 46.91% |
| 2 | Technology | 35.52% |
| 3 | Communication Services | 5.66% |
| 4 | Consumer Discretionary | 4.26% |
| 5 | Industrials | 2.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Cisco
CSCO
$457B
| $30.2M | 1.2% |
+647,110
| New | +$28.4M |
|
27
Zimmer Biomet
ZBH
$18.2B
| $30.2M | 1.19% |
+260,214
| New | +$30M |
|
28
Intuitive Surgical
ISRG
$127B
| $29.8M | 1.18% |
+157,116
| New | +$28.2M |
|
29
Snap
SNAP
$7.87B
| $28.9M | 1.14% |
1,230,181
+860,283
| +233% | +$15.3M |
|
30
Humana
HUM
$44B
| $28.3M | 1.12% |
+73,084
| New | +$27.3M |
|
31
Becton Dickinson
BDX
$45.6B
| $26.3M | 1.04% |
112,494
-28,267
| -20% | -$6.81M |
|
32
Expedia Group
EXPE
$35.6B
| $25.8M | 1.02% |
313,793
+200,685
| +177% | +$14.6M |
|
|
ALXN
33
DELISTED
Alexion Pharmaceuticals
ALXN
| $25.6M | 1.01% |
228,253
+8,104
| +4% | +$860K |
|
|
HOLX
34
DELISTED
Hologic
HOLX
| $25.5M | 1.01% |
448,058
+278,252
| +164% | +$13.7M |
|
|
OPTU
35
Optimum Communications Inc
OPTU
$290M
| $25.2M | 1% |
+1,119,965
| New | +$27.5M |
|
36
ICU Medical
ICUI
$4.22B
| $23.5M | 0.93% |
127,725
+69,822
| +121% | +$13.9M |
|
37
NVIDIA
NVDA
$4.83T
| $23.5M | 0.93% |
2,478,200
+2,349,760
| +1,829% | +$19M |
|
38
Universal Health Services
UHS
$10.1B
| $23.5M | 0.93% |
+253,389
| New | +$25.3M |
|
39
Danaher
DHR
$138B
| $22.8M | 0.9% |
145,590
+104,094
| +251% | +$14.9M |
|
40
Keysight
KEYS
$55B
| $22.6M | 0.9% |
+224,640
| New | +$22.1M |
|
|
IPHI
41
DELISTED
INPHI CORPORATION
IPHI
| $22.5M | 0.89% |
+191,458
| New | +$20.2M |
|
42
Cooper Companies
COO
$14.1B
| $22.4M | 0.89% |
+315,596
| New | +$23.4M |
|
43
Quest Diagnostics
DGX
$25.9B
| $22.1M | 0.88% |
+193,844
| New | +$20.6M |
|
44
Cirrus Logic
CRUS
$6.55B
| $21M | 0.83% |
+340,430
| New | +$23.3M |
|
45
Lyft
LYFT
$5.96B
| $20.1M | 0.8% |
609,781
+212,889
| +54% | +$6.73M |
|
46
Alibaba
BABA
$293B
| $20.1M | 0.79% |
+92,992
| New | +$19.4M |
|
|
ZGNX
47
DELISTED
Zogenix, Inc.
ZGNX
| $20M | 0.79% |
738,700
+187,545
| +34% | +$5.17M |
|
48
Regeneron Pharmaceuticals
REGN
$77.7B
| $19.2M | 0.76% |
30,722
+3,245
| +12% | +$1.84M |
|
|
PRNB
49
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $19.1M | 0.75% |
318,677
+75,901
| +31% | +$4.69M |
|
|
IMMU
50
DELISTED
Immunomedics Inc
IMMU
| $18.8M | 0.75% |
531,463
-1,409,750
| -73% | -$41.2M |
|
Similar funds
PAM
TCIIS
UIM
Woodline Partners's Q2 2020 Portfolio in Review
As of Q2 2020, Woodline Partners held 205 positions worth $2.52B, up 80% from $1.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Woodline Partners deployed $772M of net new capital in Q2 2020, opening 69 new positions and adding to 52 existing holdings. Its largest new stake was Johnson & Johnson: 418,880 shares worth $58.9M.
By sector, the portfolio is most concentrated in Healthcare at 47% of assets, up from 46% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Immunomedics Inc, an estimated $41.2M trimmed.
- Woodline Partners's largest Q2 2020 buy was Johnson & Johnson: 418,880 shares worth $58.9M.
- Woodline Partners added most to Intel in Q2 2020, an estimated $62.5M increase.
- Woodline Partners's biggest Q2 2020 reduction was Immunomedics Inc, cutting an estimated $41.2M.
- Woodline Partners fully exited Pfizer in Q2 2020, selling an estimated $65.7M.
- Woodline Partners's ten largest holdings make up 26% of its $2.52B portfolio in Q2 2020.
- Woodline Partners opened 69 new positions and closed 58 in Q2 2020.
- Woodline Partners's portfolio value rose 80% quarter-over-quarter to $2.52B.
Based on Woodline Partners's 13F filing for Q2 2020, filed 14 Aug 2020.